Francesca Barone, MD, PhD
Company: Candel Therapeutics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Combining Cell Therapies with Synergistic Treatments to Prevent Antigen Escape 2:30 pm
Uncovering combination assets to synergize cell therapies and potentiate anti-tumor response Mitigating against combinatorial toxicities to promote safe tumor regressionRead more
day: Post-Conference Day - Tackling Solid Tumors
Leveraging Viral Immunotherapies to Potentiate CAR-T Response through Combination Therapy 1:30 pm
Developing a novel viral immunotherapy platform to overcome the barriers to cell therapy efficacy Leveraging intratumoral delivery to boost CAR-T efficacy in solid tumorsRead more
day: Post-Conference Day - Tackling Solid Tumors